Steven R. Caliari is an Associate Professor in the Department of Chemical Engineering with a secondary appointment in Biomedical Engineering at the University of Virginia’s School of Engineering and Applied Science. He serves as the ChE Graduate Program Director and is a SEAS Copenhaver Fellow (2023). His research focuses on designing biomaterials to study cell-microenvironment interactions, addressing challenges in disease and tissue engineering. He holds a B.S. (2007, University of Florida), M.S. (2010), and Ph.D. (2013) in Chemical Engineering from the University of Illinois, followed by an NIH postdoctoral fellowship at the University of Pennsylvania. His research interests include biomaterials, mechanobiology, musculoskeletal tissue engineering, and advanced manufacturing for biological applications. His lab has pioneered viscoelastic hydrogel platforms and conductive collagen scaffolds, supported by NIH, NSF, DoD, and industry grants. Notable awards include the NSF CAREER Award (2021) and NIH MIRA (2020). Grants: NIH (NIGMS), NSF CAREER, V Foundation, UVA-Coulter Partnership Courses: Tissue Engineering (BME/CHE 4417), Transport Processes I (CHE 3321) Labs: Caliari Lab focuses on biomaterial design and mechanobiological studies His work bridges fundamental science and translational applications, emphasizing dynamic material systems for regenerative medicine and disease modeling.
Stephane Cotin is a Research Director at Inria and leader of the MIMESIS team, specializing in real-time physics-based medical simulations. His work focuses on surgical training, planning, and image-guided therapy, with over 200 scientific articles and the development of the open-source SOFA framework. He co-founded InSimo, Twinical, and EVE, and previously held roles at Harvard Medical School and Mitsubishi Electric Research Lab. Cotin’s research bridges imaging, robotics, and medicine to improve healthcare outcomes, emphasizing patient-specific biophysical modeling and real-time computation. His awards include the Academy of Sciences Award (2018) and Dirk Bartz Medical Prize (2015). He has advised numerous PhD students and led projects like MediTwin and PREMYOM, advancing digital twin technologies for precision medicine.
Scott L. Diamond is the Arthur E. Humphrey Professor of Chemical and Biomolecular Engineering and Bioengineering at the University of Pennsylvania's School of Engineering and Applied Sciences. He serves as Director of the Penn Center for Molecular Discovery, Director of the Penn Biotechnology Masters Program (one of the largest in the country with over 130 students), and Associate Director of the Institute for Medicine and Engineering (IME). His laboratory is located in the Roy and Diana Vagelos Laboratories at 3340 Smith Walk, 1020 Vagelos Research Laboratories, Philadelphia, PA. Diamond's research spans multiple interconnected fields in blood biology and biotechnology. His work focuses on mechanobiology, thrombolysis, coagulation, bioadhesion, gene therapy, drug/device development, proteomics, drug discovery, systems biology, and microfluidics. His laboratory has developed numerous specialized microfluidic devices for studying blood clotting under various flow conditions, including 8-channel devices for high-throughput clotting assays, side-view devices for clot structure analysis, stenosis devices for high shear clotting assays, and impingement-post devices for studying von Willebrand factor fibers. Diamond's research group has pioneered approaches to model and predict blood function using systems biology principles. His team has developed computational models that integrate reaction-transport phenomena with platelet signaling networks to predict thrombus formation under flow. These models have enabled the development of 'virtual blood' computer simulations that can predict the effectiveness of anticoagulation drugs for individual patients, contributing significantly to personalized medicine approaches in hemostasis and thrombosis. His extensive publication record demonstrates a consistent focus on understanding the fundamental mechanisms of blood clot formation and dissolution. Recent work has emphasized microfluidic approaches for point-of-care diagnostics, patient-specific modeling of platelet function, and the development of novel therapeutic strategies for thrombotic disorders. His research bridges engineering principles with clinical hematology to address significant challenges in cardiovascular medicine. NSF National Young Investigator Award NIH FIRST Award American Heart Association Established Investigator Award AIChE Allan P. Colburn Award George Heilmeier Excellence in Research Award Elected Fellow of the Biomedical Engineering Society (BMES) Diamond has secured significant research funding, including a $2.8 million NIH grant for 'Blood Systems Biology' and a $9.5 million NIH grant for the Penn Center for Molecular Discovery. His laboratory has developed numerous microfluidic devices for blood analysis and has collaborated extensively with clinicians and industry partners. Diamond has served on advisory committees for NSF, NIH, AHA, and NASA, and has consulted extensively for industry and government. With over 180 publications and patents, his work has significantly advanced the understanding of blood clotting mechanisms and the development of diagnostic and therapeutic approaches for thrombotic disorders.
Dr. Bob Beitle Jr. is a Professor of Chemical Engineering and Senior Associate Vice Chancellor for Research and Innovation at the University of Arkansas. He joined the department in 1993, earned tenure in 1998, and was promoted to Full Professor in 2006. His research spans biochemical engineering , bioseparation , fermentation , and adaptive technology for the disabled , with significant work on protein purification, catalytic nanoparticles, and sustainable bioprocesses. Education: BS, MS, PhD in Chemical Engineering from the University of Pittsburgh (1987, 1991, 1993) Dr. Beitle's research combines experimental and computational approaches, focusing on peptide-directed nanoparticle synthesis and biocatalysis . His recent publications highlight advancements in MOF-based separations , CO2 capture materials , and viral detection platforms . He has secured grants like the CAREER Award and led projects in industrial partnerships and student development . Scientific contributions include multiple patents in bioseparation and software interfaces. Awards span decades: teaching honors (1988–2007) and mentorship recognition . He serves on the Cell and Molecular Biology Program Advisory Committee and the Executive Committee for the Biochemical Technology Division of ACS . Lab initiatives involve genomic data-driven affinity tail design and membrane-assisted fermentation systems .
Mark W Grinstaff is a Professor at Boston University, leading the Grinstaff Group, which focuses on interdisciplinary biomaterials and biomedical engineering research. His work addresses healthcare challenges through innovations in diagnostics, devices, and therapeutics. He holds a B.A. from Occidental College (1987) and a Ph.D. from the University of Illinois at Urbana-Champaign (1992). Research interests include designing biodendrimers for tissue engineering, interfacial biomaterials, and conducting polymer-based sensors. Key areas span cartilage repair, drug delivery systems (e.g., anticancer, DNA), and biodegradable scaffolds. He explores nanoparticle-based imaging agents for osteoarthritis diagnosis and biomechanical assessments using computed tomography. Recent publications highlight advancements in machine learning-driven osteoarthritis classification, dual-contrast agents for cartilage imaging, and synthetic biolubricants for equine models. His group emphasizes translational research, with a focus on nanotechnology, regenerative medicine, and therapeutic delivery platforms. Grinstaff’s work is supported by grants and collaborations, though specific grants are not detailed in the text. He advises students through the Grinstaff Group, though no student names are listed here. His lab develops novel materials and devices, including polymeric adhesives and biosensors, with applications in orthopedics, oncology, and infectious diseases.
Michael Harrison is an Assistant Professor in the Department of Cell and Developmental Biology at Weill Cornell Medicine, where he leads the Regeneration and Development Lab within the Graduate School of Medical Sciences. His research focuses on vascular development and regeneration using zebrafish as a model organism, with emphasis on coronary and cerebral vasculature. Education: B.Sc. in Genetics, University of Edinburgh (2005) Ph.D. in Developmental Genetics, University of Sheffield (mentor: Vincent Cunliffe) Postdoctoral Fellowship, Saban Research Institute, Children’s Hospital Los Angeles (CIRM Fellow) Harrison's research centers on understanding how blood and lymphatic vessels form and regenerate, particularly in the heart and brain. His lab investigates coronary vessel development, the role of lymphatic systems in inflammation and regeneration, and revascularization after injury. By leveraging zebrafish genetics and advanced imaging, his work aims to uncover pathways that could be harnessed for regenerative therapies in humans. His recent publications reveal key signaling mechanisms such as Cxcr4-Cxcl12 in coronary development and the two-step formation of cardiac lymphatics. The 15 most recent articles demonstrate a strong, consistent research trajectory in vascular biology and regeneration, with increasing use of advanced techniques like single-nuclei multiomics, fluidic imaging devices, and CRISPR-based genome editing. His work spans developmental mechanisms, functional imaging, and translational applications in cardiac repair. Scientific Awards: No awards explicitly mentioned in the provided text. Harrison actively mentors a team of postdoctoral fellows, research assistants, and students, several of whom have progressed to medical school or research careers. His lab collaborates extensively, particularly with Ching-Ling Lien's group. He has secured research space and funding to support ongoing projects in cardiac and cerebral vasculature. The lab is actively recruiting rotation students from BCMB, PBSB, IMP, and Tri-Institutional programs, as well as postdoctoral researchers and research assistants, indicating an expanding research team and active grant support. Labs and Teams: Regeneration and Development Lab, Weill Cornell Medicine Collaborations with Ching-Ling Lien Lab Member of Tri-Institutional PhD Programs Active participation in BCMB, PBSB, and IMP training programs
Chao Liu is a Research Scientist at CNRS (French National Center for Scientific Research) since 2008, affiliated with the DEXTER team and the Department of Robotics, LIRMM at University of Montpellier, France. He earned his Ph.D. in Electrical & Electronic Engineering from Nanyang Technological University, Singapore (2006). Current research focuses on surgical robotics , haptics , teleoperation , and nonlinear control theory with applications in computer vision. His work addresses challenges in robotic-assisted telesurgery, including: Stable and transparent human-robot interaction through wave variable compensators and passivity filters Physiological motion compensation using spatio-temporal LSTM and dual Kalman filters EMG-based motion recognition for surgical skill assessment 3D soft-tissue reconstruction with stereo-endoscopes and deep learning Dr. Liu leads European and French projects like: TS2RT (CNRS-funded): Safer teleoperation with motion compensation ROBACUS (ANR-funded): Needle positioning with MPC control HaTUMoCo (CNRS-funded): Haptic teleoperation with uncertainty handling ARAKNES (EU-funded): Microrobotic systems for endoluminal surgery Scientific honors include Senior Member of IEEE and Member of Sigma Xi . He supervises Ph.D. and Master's students working on topics such as concentric tube robot optimization, haptic teleoperation, and EMG-based force estimation. Dr. Liu serves on IEEE Technical Committees for Telerobotics and Haptics , and as Technical Editor of IEEE/ASME Transactions on Mechatronics.
Ueli Grossniklaus is an Ordinary Professor at the University of Zurich within the Faculty of Mathematical and Natural Sciences , affiliated with the Department of Plant and Microbiology . His work focuses on plant developmental biology, particularly epigenetic and genetic mechanisms governing reproduction and adaptation. Key Courses: Epigenetics, Plant Biology Workshop, Group Seminars on Current Research Laboratory Techniques: Advanced methods in plant cell mechanics, transcriptomics, and genome editing Research Interests span plant epigenetics, reproductive biology, and the interplay between environmental stress and genetic regulation. He investigates: Mechanistic control of gametogenesis and fertilization Epigenetic contributions to plant adaptation Evolutionary implications of asexual reproduction Biophysical forces in plant cell growth Publication Trends (2025–2018) reveal expertise in: Arabidopsis and fern model systems Epigenetic regulation (DNA methylation, histone dynamics) Apomixis and hybrid seed failure mechanisms Biomechanics of pollen tubes and carnivorous plants Genome editing tools (CRISPR) and long-read sequencing Scientific Collaborations include interdisciplinary projects on: Microfluidic devices for plant cell analysis Gene drive ecology and ethics 3D imaging of plant reproductive structures Advising and Grants focus on mentoring through research internships in developmental biology, genetics, and systems biology. His lab engages in: Epigenetic response to environmental stress Cell wall mechanics in reproduction Computational modeling of plant growth Laboratory Teams integrate plant biologists, bioengineers, and computational scientists to study: Mechanistic gene regulation Evolutionary developmental biology Microrobotics for cellular force measurement
João F. Mano is a Full Professor at the Department of Chemistry, University of Aveiro, and Director of the Doctoral Program on Biotechnology. He leads the COMPASS Research Group and serves as Vice-Director at CICECO - Aveiro Institute of Materials. His academic appointments include Invited Professor at University of Lorraine (France), Visiting Professor at KAIST (South Korea), and Adjunct Professor at Ajou University (South Korea). Education: PhD in Chemistry (1996, Technical University of Lisbon); D.Sc. in Tissue Engineering, Regenerative Medicine and Stem Cells (2012, University of Minho) Research Interests focus on Biomaterials for Regenerative Medicine , integrating Nanotechnology , Microtechnology , and Biofabrication . His group develops Bioinspired Materials using polymer chemistry, Decellularized Extracellular Matrix , and 3D Bioprinting to engineer Cell Microenvironments for therapeutic applications. Recent Publications highlight advancements in Human-Derived Hydrogels , Photopolymerizable Scaffolds , Magneto-Responsive Biomaterials , and Programmable Bioinks . Trends show emphasis on Organ-on-a-Chip integration, Smart Living Materials , and Green Bioprinting methodologies. Scientific Awards include: European Research Council Advanced Grants (2015, 2020) Fellow at IUPAC, European Academy of Sciences, and American Institute of Medical and Biological Engineering ERC Proof of Concept Grants Doctor Honoris Causa from University of Lorraine and Utrecht UNESCO Chair on Biomaterials George Winter Award (European Society for Biomaterials) Supervisions & Collaborations encompass 74+ MSc, 26+ PhD students, and 40+ postdocs. He co-founded METATISSUE and CELLULARIS Biomodels , and serves as Editor-in-Chief of Materials Today Bio .
Guojun Chen is an Assistant Professor at the Department of Biomedical Engineering and a member of the Rosalind & Morris Goodman Cancer Institute (GCI) at McGill University . His research focuses on engineering intelligent biomaterials for precision medicine , with emphasis on non-viral genome editing , cold atmospheric plasma (CAP) therapy , and biomaterials-mediated immunotherapy . The lab operates in a multidisciplinary environment , integrating principles from materials science , chemistry , biology , and health sciences . Education : Ph.D. from University of Wisconsin-Madison (2017), Postdoc at UCLA (2020) Research Themes : Genome Editing Delivery : Designing non-viral vectors for efficient CRISPR/Cas9 delivery in vivo. CAP-mediated Immunotherapy : Developing portable cold plasma devices to synergize with immune checkpoint blockade and study CAP’s immunological mechanisms. Biomaterials-based Immunotherapy : Reprogramming tumor microenvironments using bioresponsive materials to enhance immune responses. Publication Trends : Recent work spans responsive nanomaterials , genomic editing systems , and plasma oncology , with a focus on cancer immunotherapy , diabetes diagnostics , and bioinspired medical devices . Scientific Awards : Canada Research Chair (2024, 2025) McGill's President's Prize for Emerging Researchers (2025) FRQS Chercheurs-boursiers (2022) Chinese Association for Biomaterials Young Investigator Award (2022) NSERC Discovery Grant (2021) Advising & Grants : Supervises 14 current graduate and undergraduate students. Secured $5M+ in funding from CIHR , NSERC , CCS , and CFI , including multi-institutional collaborations with Dr. Morag Park , Dr. Réjean Lapointe , and Dr. Ian Watson .
Dr. Joanna Deaton Bertram is an Assistant Professor in the Thomas Lord Department of Mechanical Engineering and Materials Science at Duke University’s Pratt School of Engineering. She concurrently holds an Assistant Professor appointment in Surgery, underscoring her interdisciplinary commitment to advancing medical robotics. Dr. Bertram leads a research laboratory devoted to the design, modeling, and control of robotic systems for surgical and interventional applications, working closely with Duke’s clinical and engineering communities. Education Ph.D. in Robotics, Georgia Institute of Technology, 2024 M.S. in Mechanical Engineering, Georgia Institute of Technology, 2024 B.S. in Biomedical Engineering, Georgia Institute of Technology, 2018 Research Interests Dr. Bertram’s research program is centered on medical robotics , with particular emphasis on continuum robotics and image-guided interventions . Her work integrates novel mechanical design with advanced control algorithms and smart materials to create robotic systems capable of navigating complex anatomical pathways. A hallmark of her approach is the incorporation of real-time fiber-optic shape and force sensing (using Fiber Bragg Grating technology) to provide surgeons with unprecedented feedback during procedures. Application domains include steerable needles for brachytherapy , robotic guidewires for endovascular surgery , and pediatric neuroendoscopy . Publication Themes Across more than fifteen peer-reviewed articles, Dr. Bertram has systematically advanced the state of the art in surgical robotics , fiber-optic sensing , and robotic system modeling . Her 2024 tutorial on Nitinol and Tungsten tendon attachment techniques provides practical guidance for building highly articulated continuum robots, while her 2023 series on the COAST guidewire robot demonstrates model-based design and simultaneous shape/force sensing for large-deflection medical devices. Earlier work explored 3D-printed patient-specific robotic tools and carbon-nanotube flexible sensors, illustrating a trajectory from fundamental sensor research to full robotic system integration. Scientific Recognition & Collaboration Although no major external awards are explicitly listed, Dr. Bertram’s publications in top-tier venues such as IEEE Robotics and Automation Letters , IEEE Transactions on Medical Robotics and Bionics , and IEEE/ASME Transactions on Mechatronics attest to strong peer recognition. She actively invites motivated graduate students, post-docs, and research staff to join her lab, fostering an open and interdisciplinary environment. Advising & Grants Dr. Bertram’s lab is presently recruiting trainees at all levels. While specific funded grants are not enumerated, her dual departmental appointments and extensive publication record suggest active federal or foundation support. Prospective students and collaborators are encouraged to contact her directly at joanna.d.bertram@duke.edu . Laboratory & Teams Dr. Bertram directs a laboratory within Duke University’s Pratt School of Engineering that collaborates closely with clinicians in the School of Medicine. The group focuses on rapid prototyping of medical devices, in-vitro and ex-vivo validation, and translation of robotic technologies to the operating room.
Dr. Mortaza Saeidi-Javash is an Assistant Professor in the Department of Mechanical and Aerospace Engineering at California State University, Long Beach (CSULB). He joined in Fall 2022 following his Ph.D. in Mechanical Engineering from the University of Notre Dame, where he received the Prince Engineering Fellowship and Dehner Graduate Fellowship. His research focuses on developing next-generation flexible electronics using advanced materials and 3D printing technologies, particularly thermoelectric devices for wearable applications and multifunctional sensors for structural health monitoring. Dr. Saeidi-Javash's academic background includes interdisciplinary work combining materials science, additive manufacturing, and machine learning. His Ph.D. research emphasized aerosol jet printing and ultrafast flash sintering to create high-performance, low-cost thermoelectric devices. He has published extensively in journals like Advanced Materials and Nano Energy , with a focus on flexible electronics, energy harvesting, and sensor integration. His recent publications highlight innovations in machine learning-aided materials discovery, plasma sintering processes, and hybrid printing methods. These contributions address challenges in scalable manufacturing, energy efficiency, and wearable technology applications. Dr. Saeidi-Javash’s work bridges gaps between fundamental materials research and practical engineering solutions for sustainable energy systems and smart devices. Awards: Prince Engineering Fellowship (University of Notre Dame) Dehner Graduate Fellowship in Engineering (University of Notre Dame) Advising & Office Hours: Office: ECS-647 Office Hours: Wednesday 12:00-2:00 PM Advising Hours: Thursday 12:30-1:30 PM His research lab focuses on additive manufacturing of functional materials, with ongoing projects in thermoelectric energy conversion, wearable sensors, and biomaterials for cardiac tissue engineering.
Adam Feinberg is a Professor in the Departments of Biomedical Engineering and Materials Science and Engineering at Carnegie Mellon University (CMU). He leads the Regenerative Biomaterials & Therapeutics Group, focusing on cell-material interactions, 3D bioprinting, and bioengineered tissues. His work integrates nanofabrication, molecular biology, and 3D imaging to address challenges in muscle repair, corneal regeneration, and cancer. Key innovations include the FRESH bioprinting platform, enabling soft ECM gel-based constructs, and ECM shrink-wrapping techniques for cell encapsulation. Feinberg holds a Ph.D. and MS in Biomedical Engineering from the University of Florida (2004, 2002) and a BS in Materials Science and Engineering from Cornell University (1999). He has secured major grants, including ARPA-H funding for diabetes treatments and Canada’s New Frontiers Fund for heart disease therapies. His research has led to over 45 peer-reviewed articles and 20 patents. His scientific awards include the NIH Director’s New Innovator Award and NSF CAREER Award. Media highlights include breakthroughs in vascularized tissue models and biodegradable actuators. Feinberg collaborates widely, advancing clinical translation of bioprinted tissues and sustainable bio-bots.
Jouko Peltonen is a Professor in Chemistry at Åbo Akademi University's Faculty of Natural Sciences and Engineering. He leads the Laboratory of Molecular Science and Technology, focusing on sustainable material development and biomedical applications. His work aligns with UN Sustainable Development Goals through green chemistry innovations. Ph.D. in Chemistry (Åbo Akademi, 1994) Licentiate in Chemistry (Åbo Akademi, 1992) Master's in Chemistry (University of Helsinki, 1988) Peltonen's research spans materials science , polymer chemistry , and sustainable technology , with emphasis on nanocellulose composites , antibacterial materials , and bio-based packaging . Recent projects explore biofilm modeling and lignin valorization. His publications (216 total) demonstrate interdisciplinary impact across biomedical engineering , environmental science , and chemical manufacturing . Key collaborations include NordForsk-funded initiatives and EU projects like PACKER 2020. Research grants include: Printed Intelligence Infrastructure (Academy of Finland, 2024-2028) Nordic POP (NordForsk, 2018-2025) ABC-Health (Jane och Aatos Erkkos Foundation, 2021-2024)
Karen S. Anderson, M.D., Ph.D. is a Professor of Medicine at Mayo Clinic in Phoenix, Arizona, where she serves as a Contract Physician in the Division of Hematology/Oncology within the Department of Internal Medicine. Her clinical practice focuses on breast cancer, and she is affiliated with the Mayo Clinic Comprehensive Cancer Center and the Breast Clinic. As an active researcher, Dr. Anderson leads clinical trials in breast cancer immunotherapy and biomarker development. Dr. Anderson's educational background includes: Medical Scientist Training Program (MD), Duke University School of Medicine (1994) Ph.D. in Microbiology and Immunology, Duke University (1994) BA in Chemistry, University of Virginia (1986) Internship and Residency in Internal Medicine, Brigham and Women's Hospital, Boston Fellowship in Adult Hematology and Oncology, Dana Farber Cancer Institute Dr. Anderson's research focuses on cancer immunology with particular emphasis on breast cancer biomarkers, ovarian cancer biomarkers, pancreatic cancer biomarkers, cancer vaccines, and HPV-related cancers. Her work spans from basic immunology to clinical applications, with a strong focus on translating laboratory findings into clinical practice. She has developed innovative approaches for early cancer detection and has been instrumental in advancing breast cancer immunotherapy through clinical trials. Analysis of Dr. Anderson's recent publications reveals a consistent focus on breast cancer immunology, biomarker discovery, and HPV-related cancers. Her work integrates molecular biology, immunology, and clinical oncology to develop novel diagnostic and therapeutic approaches. Notably, her research has expanded to include computational approaches for neoantigen prediction and has addressed public health challenges including HPV-related cancer screening and even COVID-19 vaccine strategies. Dr. Anderson has received several prestigious awards: Outstanding Faculty Mentor Arizona State University Faculty Women's Association (2020) Chief Resident West Roxbury VA Hospital (1996) Phi Beta Kappa University of Virginia (1986) Merck Scholar (1986) Alpha Omega Alpha Honor Medical Society (1986) Echols Scholar University of Virginia (1982) Dr. Anderson has been actively involved in mentoring students and early-career researchers, serving on numerous thesis committees at Arizona State University across multiple departments including Molecular and Cellular Biology, Chemistry, and the Barrett Honors College. Her research is supported by multiple grants from the National Cancer Institute, including her role as Co-Chair of the Breast and Gynecologic Cancers Collaborative Group within the Early Detection Research Network. Dr. Anderson is a key member of the Arizona Biomarker Alliance Executive Committee and has established collaborative research teams focused on cancer biomarker discovery and validation. Her laboratory work integrates protein microarray technology, immunology, and cancer genomics to develop novel diagnostic and therapeutic approaches for breast and HPV-related cancers.
